Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly;Seguridad y eficacia del hierro intravenoso en la anemia aguda por fractura trocantérea de cadera en el anciano

Medicina Clinica

Volumn 123, Issue 8, 2004, Pages 281-285

  Espiérrez, Jorge Cuenca ^a   Erce, José Antonio García ^a   Martínez, Ángel A ^a   Solano, Víctor Manuel ^a   Aranda, Francisco Javier Modrego ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b Hospital Comarcal   (Spain)

Author keywords

Hip fracture; Intravenous iron; Transfusion

Indexed keywords

FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN;

AGED; AGING; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HIP FRACTURE; HOSPITALIZATION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE CARE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 5644288734     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(04)74493-0     Document Type: Article

References (45)

1. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, et al. Risk of bacterial infection associated with allogenic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999;39:694-700.
2. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, et al. Perioperative blood transfusion and postoperative mortality. JAMA 1998;279:199-205.
3. Carson JL, Terrin ML, Barton FB, Aaron R, Greenburg AG, Heck DA, et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998;38:522-9.
4. Cuenca J, Martínez AA, Panisello JJ, Herrera A, Sola A. Estudio de la evolución de la hemoglobina y el hematocrito según el tipo de fractura de cadera. Rev Ortop Traumatol 2002;1:54-7.
5. Goodnough LT, Merkel K. Parenteral iron and recombinant human erythropoietin therapy to stimulate erythropoiesis in patients undergoing repair of hip fracture. Hematology 1996;1:163-6.
6. Goodnough LT, Ridell J, Verbrugge D, Marcus RE. Blood transfusions in hip fracture patients: implications for blood conservation programs. J Orthop Trauma 1993;7:47-51.
7. Koval KJ, Rosenberg AD, Zuckerman JD, Aharonoff GB, Skovron ML, Bernstein RL, et al. Does blood transfusion increase the risk of infection after hip fracture? J Orthop Trauma 1997;11:260-5.
8. Levi N, Sandberg T. Blood transfusion and postoperative wound infection in intracapsular femoral neck fractures. Bull Hosp If Dis 1998;57: 69-73.
9. Poses RM, Berlin JA, Noveck H, Lawrence VA, Huber EC, O'Hara DA, et al. How you look determines what you find: severity of illness and variation in blood transfusion for hip fracture. Am J Med 1998;105:198-206.
10. Swain DG, Nightingale PG, Patel JV. Blood transfusion requirements in femoral neck fracture. Injury 2000;31:7-10.
11. Zuccala G, Pahor N, Landi F, Gasparini G, Pagano F, Cabonin P, et al. Use of calcium antagonits and need for preoperative transfusion in older patients with hip fracture: observational study. BMJ 1997;314:643-4.
12. Carson JL, Poses RM, Spence RK, Bonavita G. Severity of anaemia and operative mortality and morbidity. Lancet 1988;1:727-9.
13. Larocque B, Brien WF, Gilbert, K. The utility and prediction of allogeneic blood transfusion use in orthopedic surgery. Transfus Med Rev 1999;13: 124-31.
14. Levi N. Blood transfusion requirements in intracapsular femoral neck fractures. Injury 1996;27: 709-11.
15. McBride DJ, Stother IG. Blood transfusion requirements in elderly patients with surgically treated fractures of the femoral neck. J R Coll Surg Edimb 1988;33:311-3.
16. Garcia-Erce JA, Cuenca J, Solano V. Factores predictivos de la necesidad de transfusion en la fractura subcapital de cadera en pacientes de más de 65 años. Med Clin (Barc) 2003;120:161-6.
17. Agarwal N, Murphy JG, Cayten CG, Stahl WM. Blood transfusion increases risk of infection in trauma. Arch Surg 1993;128:171-7.
18. Ford CD, Van Moorleghem G, Menlove RL. Blood transfusion and postoperative wound infection. Surgery 1993;113:603-7.
19. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991;31:212-7.
20. Polk HC. Factors influencing the risk of infection after trauma. Am J Surg 1993;165(Suppl 2A):2-7.
21. Steinitz D, Harvey EJ, Leighton RK, Petrie DP. Is homologous blood transfusion a risk factor for infection after hip replacement? Can J Surg 2001;44:355-8.
22. Clemens J, Spivak JL. Serum immunoreactive erythropoietin during the perioperative period. Surgery 1994;115:510-5.
23. Biesma DH, Van de Wiel A, Beguin Y, Keraaijenhagen RJ, Marx JJM. Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur J Clin Invest 1995; 25:383-9.
24. Van Iperen CE, Kraaijenhagen RJ, Biesma DH, Beguin Y, Marx JJM, Van de Wiel A. Iron metabolism and erythropoiesis after surgery. Br J Surg 1998;85:41-5.
25. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95.
26. Bernière J, Dehullu JP, Gall O, Murat I. Intravenous iron in the treatment of postoperative anaemia in surgery of the spine in infants and adolescents. Rev Chir Orthop 1998;84:319-22.
27. Mays T, Mays T. Intravenous iron-dextran therapy in the treatment of anaemia occurring in surgical, gynecologic and obstetric patients. Surg Gynecol Obstet 1976;143:381-4.
28. Beris P. Perisurgical intravenous iron therapy. TATM 1999;4:35-8.
29. Algora M, Fernández A, Gómez JL, Martín C, Prats I, Puig N, et al. Guía sobre la indicación de la transfusión de glóbulos rojos, plaquetas y productos plasmáticos lábiles. Med Clin (Barc) 1999;113:471-4.
30. Müller ME, Nazarian S, Koch P. Classification AO des fractures. Berlin, Heilderberg: Springer, 1987.
31. New classification of physical status. Anesthesiology 1963;24:111.
32. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. Centers for Disease Control definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8.
33. De Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC. Baseline haemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996;25:533-42.
34. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on operative transfusion requirements in patients having a major orthopedic operation. J Bone Joint Surg 1996;78A:62-72.
35. Goldberg MA, McCutchen JW, Jove M, DiCesare P, Friedman RJ, Poss R, et al. A safety and efficacy comparison study of two dosing regimens of Epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996;25:544-52.
36. Schmidt AH, Templeman DC, Kyle RF. Blood conservation in hip trauma. Clin Orthop 1998; 357:68-73.
37. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17.
38. García-Erce JA, Solano VM, Cuenca J, Ortega P. La hemoglobina preoperatoria como único factor predictor de las necesidades transfusionales en la artroplastia de rodilla. Rev Esp Anestesiol Reanim 2002;49:254-60.
39. Cuenca J. Estudio epidemiológico de las fracturas de tercio proximal de cadera en el paciente anciano [tesis doctoral]. Zaragoza: Universidad de Zaragoza, 2001.
40. Parker MJ, Pryor GA. Internal fixation or arthroplasty for displaced cervical hip fractures in the elderly: a randomized trial of 208 patients. Acta Orthop Scand 2000;71:440-6.
41. Zauber NP, Zauber AG, Gordon FJ, Tillis AC, Leeds HC, Berman E, et al. Iron supplementation after femoral head replacement for patients with normal iron stores. JAMA 1992;267:525-7.
42. Macdougall IC. Intravenous administration of iron in epoetin-treated hemodialysis patients - which drugs, wich regimen? Nephrol Dial Transplant 2000;15:1743-5.
43. Grasa JM, García-Erce JA, Herrero L, Giralt M. Eritropoyetina y cirugía de cadera a un testigo de Jehová anémico con espondilitis anquilopoyética, hepatopatía crónica y enfermedad de Cröhn. Rev Esp Anestesiol Reanim 2002;49:113-4.
44. Sculco TP. Blood management in orthopedic surgery. Am J Surg 1995;170(Suppl 6A):60-3.
45. Llau Pitarch JV. Medicina transfusional perioperatoria. Rev Esp Anestesiol Reanim 2001;48: 103-5.